Federal solicitation · NOI-CC-OLAO-26-006103 · back to recent
Intent to Sole Source - Reagents and Consumables required for Systemic Autoimmune Rheumatic Diseases.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NAICS 541715 · NONE · Deadline 2026-06-02T12:00:00-04:00
Solicitation description
This is a Notice of Intent, not a request for proposal. The National Institute of Health intends to negotiate on an other than full and open competition basis with the following vendor: 10X Genomics, Inc. Acquisition Description: The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a firm-fixed priced contract to 10X Genomics Inc. for the acquisition of reagents and consumables required for Systemic Autoimmune Rheumatic Diseases. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006103) by 12:00 PM eastern standard time on 06/02/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Vendor field in NAICS 541715 (12m)
Top 5 vendors by trailing-12m obligated dollars across this NAICS code, $3,164.9M total.
| LOCKHEED MARTIN CORPORATION | 16.2% |
| RAYTHEON COMPANY | 15.4% |
| LEIDOS BIOMEDICAL RESEARCH INC | 15.2% |
| THE MITRE CORPORATION | 11.2% |
| NORTHROP GRUMMAN SYSTEMS CORPORATION | 9.7% |
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Evaluation and Conduct of Computational and Alternative... | HEALTH AND HUMAN... | $79.3M | same agency naics |
| 2026 NIAID DMID Omnibus Broad Agency Announcement | HEALTH AND HUMAN... | $23.9M | same agency naics |
| Analytical Services Center for Medications Development Program | HEALTH AND HUMAN... | $5.0M | same agency naics |
| Notice of Intent to Sole Source – 10x Genomics, Inc. | HEALTH AND HUMAN... | - | same agency naics |
| Restorative and health-Enhancing Sleep Time (REST) | HEALTH AND HUMAN... | - | same agency naics |
| Office-Wide Innovative Solutions Opening for Scalable... | HEALTH AND HUMAN... | - | same agency naics |
| Best Pharmaceuticals for Children Act DCC | HEALTH AND HUMAN... | - | same agency naics |
| Medicinal Chemistry Support Program for Therapeutic... | HEALTH AND HUMAN... | - | same agency naics |
Data this profile does NOT cover
- No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.